LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Dectin-1 Signaling Update: New Perspectives for Trained Immunity.

    Mata-Martínez, Pablo / Bergón-Gutiérrez, Marta / Del Fresno, Carlos

    Frontiers in immunology

    2022  Volume 13, Page(s) 812148

    Abstract: The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses. However, over time, different ligands both of microbial-derived and endogenous origin have ... ...

    Abstract The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses. However, over time, different ligands both of microbial-derived and endogenous origin have been shown to be recognized by Dectin-1. The outcomes of this recognition are diverse, including pro-inflammatory responses such as cytokine production, reactive oxygen species generation and phagocytosis. Nonetheless, tolerant responses have been also attributed to Dectin-1, depending on the specific ligand engaged. Dectin-1 recognition of their ligands triggers a plethora of downstream signaling pathways, with complex interrelationships. These signaling routes can be modulated by diverse factors such as phosphatases or tetraspanins, resulting either in pro-inflammatory or regulatory responses. Since its first depiction, Dectin-1 has recently gained a renewed attention due to its role in the induction of trained immunity. This process of long-term memory of innate immune cells can be triggered by β-glucans, and Dectin-1 is crucial for its initiation. The main signaling pathways involved in this process have been described, although the understanding of the above-mentioned complexity in the β-glucan-induced trained immunity is still scarce. In here, we have reviewed and updated all these factors related to the biology of Dectin-1, highlighting the gaps that deserve further research. We believe on the relevance to fully understand how this receptor works, and therefore, how we could harness it in different pathological conditions as diverse as fungal infections, autoimmunity, or cancer.
    MeSH term(s) Lectins, C-Type/metabolism ; Ligands ; Phagocytosis ; Signal Transduction ; beta-Glucans
    Chemical Substances Lectins, C-Type ; Ligands ; beta-Glucans ; dectin 1
    Language English
    Publishing date 2022-02-14
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2022.812148
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Heat-killed

    Minute, Luna / Bergón-Gutiérrez, Marta / Mata-Martínez, Pablo / Fernández-Pascual, Jaime / Terrón, Verónica / Bravo-Robles, Laura / Bıçakcıoğlu, Gülce / Zapata-Fernández, Gabriela / Aguiló, Nacho / López-Collazo, Eduardo / Del Fresno, Carlos

    iScience

    2024  Volume 27, Issue 2, Page(s) 108869

    Abstract: Trained immunity (TI) represents a memory-like process of innate immune cells. TI can be initiated with various compounds such as fungal β-glucan or the tuberculosis vaccine, Bacillus Calmette-Guérin. Nevertheless, considering the clinical applications ... ...

    Abstract Trained immunity (TI) represents a memory-like process of innate immune cells. TI can be initiated with various compounds such as fungal β-glucan or the tuberculosis vaccine, Bacillus Calmette-Guérin. Nevertheless, considering the clinical applications of harnessing TI against infections and cancer, there is a growing need for new, simple, and easy-to-use TI inducers. Here, we demonstrate that heat-killed
    Language English
    Publishing date 2024-01-11
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2024.108869
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases.

    Segura-Collar, Berta / Mata-Martínez, Pablo / Hernández-Laín, Aurelio / Sánchez-Gómez, Pilar / Gargini, Ricardo

    The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry

    2021  Volume 28, Issue 3, Page(s) 222–237

    Abstract: The brain is endowed with a unique cellular composition and organization, embedded within a vascular network and isolated from the circulating blood by a specialized frontier, the so-called blood-brain barrier (BBB), which is necessary for its proper ... ...

    Abstract The brain is endowed with a unique cellular composition and organization, embedded within a vascular network and isolated from the circulating blood by a specialized frontier, the so-called blood-brain barrier (BBB), which is necessary for its proper function. Recent reports have shown that increments in the permeability of the blood vessels facilitates the entry of toxic components and immune cells to the brain parenchyma and alters the phenotype of the supporting astrocytes. All of these might contribute to the progression of different pathologies such as brain cancers or neurodegenerative diseases. Although it is well known that BBB breakdown occurs due to pericyte malfunctioning or to the lack of stability of the blood vessels, its participation in the diverse neural diseases needs further elucidation. This review summarizes what it is known about BBB structure and function and how its instability might trigger or promote neuronal degeneration and glioma progression, with a special focus on the role of pericytes as key modulators of the vasculature. Moreover, we will discuss some recent reports that highlights the participation of the BBB alterations in glioma growth. This pan-disease analysis might shed some light into these otherwise untreatable diseases and help to design better therapeutic approaches.
    MeSH term(s) Blood-Brain Barrier/metabolism ; Brain/metabolism ; Central Nervous System Diseases ; Glioma/metabolism ; Glioma/pathology ; Humans ; Pericytes/physiology
    Language English
    Publishing date 2021-01-15
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1233753-5
    ISSN 1089-4098 ; 1073-8584
    ISSN (online) 1089-4098
    ISSN 1073-8584
    DOI 10.1177/1073858420985838
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung.

    Moreo, Eduardo / Jarit-Cabanillas, Aitor / Robles-Vera, Iñaki / Uranga, Santiago / Guerrero, Claudia / Gómez, Ana Belén / Mata-Martínez, Pablo / Minute, Luna / Araujo-Voces, Miguel / Felgueres, María José / Esteso, Gloria / Uranga-Murillo, Iratxe / Arias, Maykel / Pardo, Julián / Martín, Carlos / Valés-Gómez, Mar / Del Fresno, Carlos / Sancho, David / Aguiló, Nacho

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 6090

    Abstract: Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer. Previous studies have demonstrated that intravenous (IV) administration of BCG is well- ... ...

    Abstract Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer. Previous studies have demonstrated that intravenous (IV) administration of BCG is well-tolerated and effective in preventing tuberculosis infection in animals. Here, we examine IV BCG in several preclinical lung tumor models. Our findings demonstrate that BCG inoculation reduced tumor growth and prolonged mouse survival in models of lung melanoma metastasis and orthotopic lung adenocarcinoma. Moreover, IV BCG treatment was well-tolerated with no apparent signs of acute toxicity. Mechanistically, IV BCG induced tumor-specific CD8
    MeSH term(s) Mice ; Animals ; BCG Vaccine ; Urinary Bladder Neoplasms/pathology ; CD8-Positive T-Lymphocytes ; Administration, Intravenous ; Immunity, Cellular ; Killer Cells, Natural ; Lung/pathology ; Lung Neoplasms/drug therapy
    Chemical Substances BCG Vaccine
    Language English
    Publishing date 2023-10-04
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-41768-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals.

    Lozano-Rodríguez, Roberto / Avendaño-Ortíz, José / Terrón, Verónica / Montalbán-Hernández, Karla / Casalvilla-Dueñas, José / Bergón-Gutiérrez, Marta / Mata-Martínez, Pablo / Martín-Quirós, Alejandro / García-Garrido, Miguel Ángel / Del Balzo-Castillo, Álvaro / Peinado, María / Gómez, Laura / Llorente-Fernández, Irene / Martín-Miguel, Gema / Herrero-Benito, Carmen / López-Morejón, Lissette / Vela-Olmo, Carmen / Cubillos-Zapata, Carolina / López-Collazo, Eduardo /
    Del Fresno, Carlos

    Frontiers in immunology

    2023  Volume 14, Page(s) 1136029

    Abstract: Introduction: COVID-19 vaccines based on mRNA have represented a revolution in the biomedical research field. The initial two-dose vaccination schedule generates potent humoral and cellular responses, with a massive protective effect against severe ... ...

    Abstract Introduction: COVID-19 vaccines based on mRNA have represented a revolution in the biomedical research field. The initial two-dose vaccination schedule generates potent humoral and cellular responses, with a massive protective effect against severe COVID-19 and death. Months after this vaccination, levels of antibodies against SARS-CoV-2 waned, and this promoted the recommendation of a third vaccination dose.
    Methods: We have performed an integral and longitudinal study of the immunological responses triggered by the booster mRNA-1273 vaccination, in a cohort of health workers previously vaccinated with two doses of the BNT162b2 vaccine at University Hospital La Paz located in Madrid, Spain. Circulating humoral responses and SARS-CoV-2-specific cellular reactions, after
    Results: All these analyses indicated that differential responses to vaccination due to a previous SARS-CoV-2 infection were balanced following the boost. The increase in circulating humoral responses due to this booster dropped after 6 months, whereas T-cell-mediated responses were more stable along the time. Finally, all the analyzed immunological features were dampened in response to the Omicron variant of concern, particularly late after the booster vaccination.
    Conclusion: This work represents a follow-up longitudinal study for almost 1.5 years, analyzing in an integral manner the immunological responses triggered by the prime-boost mRNA-based vaccination schedule against COVID-19.
    MeSH term(s) Humans ; SARS-CoV-2 ; COVID-19/prevention & control ; 2019-nCoV Vaccine mRNA-1273 ; BNT162 Vaccine ; COVID-19 Vaccines ; Longitudinal Studies ; Vaccination
    Chemical Substances 2019-nCoV Vaccine mRNA-1273 (EPK39PL4R4) ; BNT162 Vaccine ; COVID-19 Vaccines
    Language English
    Publishing date 2023-04-21
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1136029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.

    Cejalvo, Teresa / Gargini, Ricardo / Segura-Collar, Berta / Mata-Martínez, Pablo / Herranz, Beatriz / Cantero, Diana / Ruano, Yolanda / García-Pérez, Daniel / Pérez-Núñez, Ángel / Ramos, Ana / Hernández-Laín, Aurelio / Martín-Soberón, María Cruz / Sánchez-Gómez, Pilar / Sepúlveda-Sánchez, Juan M

    Cancers

    2020  Volume 12, Issue 11

    Abstract: Background: Gliomas remain refractory to all attempted treatments, including those using immune checkpoint inhibitors. The characterization of the tumor (immune) microenvironment has been recognized as an important challenge to explain this lack of ... ...

    Abstract Background: Gliomas remain refractory to all attempted treatments, including those using immune checkpoint inhibitors. The characterization of the tumor (immune) microenvironment has been recognized as an important challenge to explain this lack of response and to improve the therapy of glial tumors.
    Methods: We designed a prospective analysis of the immune cells of gliomas by flow cytometry. Tumors with or without
    Results: We observed that few immune cells infiltrate mutant
    Conclusions: We have confirmed the reduced infiltration of immune cells in
    Language English
    Publishing date 2020-11-02
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers12113230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top